NASDAQ · BNTX
Healthcare · Biotechnology
$88.17
Down-$0.96 (-1.08%)
Updated Nov 1, 2026, 9:24 PM
SID Score
4.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · BNTX
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
BNTX closed at $88.17 after 20 trading sessions, down 9.70% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $89.22 | $90.316 | $87.44 | $88.17 | 631.92K |
| Oct 29, 2026 | $88.50 | $89.6599 | $87.77 | $89.13 | 692.72K |
| Oct 28, 2026 | $86.52 | $88.19 | $85.81 | $87.99 | 870.56K |
| Oct 27, 2026 | $86.19 | $87.27 | $85.00 | $87.06 | 1.08M |
| Oct 26, 2026 | $86.00 | $88.87 | $85.85 | $86.86 | 1.41M |
| Oct 23, 2026 | $89.34 | $89.86 | $87.52 | $88.115 | 838.7K |
| Oct 22, 2026 | $90.75 | $92.7299 | $89.03 | $89.67 | 1.16M |
| Oct 21, 2026 | $91.25 | $92.35 | $91.0157 | $91.29 | 1.11M |
| Oct 20, 2026 | $89.50 | $91.44 | $88.565 | $91.17 | 1.84M |
| Oct 19, 2026 | $88.10 | $89.795 | $87.725 | $89.21 | 1.34M |
| Oct 16, 2026 | $90.14 | $90.14 | $87.36 | $87.71 | 1.1M |
| Oct 15, 2026 | $88.92 | $90.72 | $88.45 | $90.20 | 1.08M |
| Oct 14, 2026 | $89.01 | $90.50 | $88.57 | $88.66 | 1.13M |
| Oct 13, 2026 | $92.36 | $93.08 | $88.85 | $89.01 | 1.95M |
| Oct 12, 2026 | $97.61 | $98.60 | $95.75 | $95.84 | 1.28M |
| Oct 9, 2026 | $92.45 | $97.40 | $92.30 | $96.96 | 1.32M |
| Oct 8, 2026 | $93.81 | $94.45 | $91.64 | $92.06 | 1.21M |
| Oct 7, 2026 | $95.17 | $97.46 | $93.92 | $95.25 | 828.08K |
| Oct 6, 2026 | $99.49 | $100.02 | $95.31 | $95.73 | 899.39K |
| Oct 5, 2026 | $96.74 | $98.785 | $95.20 | $97.64 | 1.44M |
The latest Smart Investors Daily articles mentioning BNTX.
Company
Market Activity
Research & News
BNTX research
Company profile and research snapshot.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 14, 2026 | Canaccord Genuity | Buy | — |
| Oct 7, 2026 | Morgan Stanley | Overweight | — |
| Sep 8, 2026 | BMO Capital | Market Perform | — |
| Aug 31, 2026 | Canaccord Genuity | Buy | — |
| Aug 5, 2026 | Evercore ISI Group | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
Bristol Myers tops Q3 earnings and revenue estimates as Growth Portfolio sales and Eliquis demand drive growth, but higher IPRD charges prompt a cut to 2026 EPS guidance.
Yahoo · Oct 28, 2026
BioNTech (NasdaqGS:BNTX) and DualityBio reported positive topline results from the DYNASTY-Breast02 Phase 3 trial in HR+/HER2-low metastatic breast cancer, including a statistically significant improvement in progression-free survival. The study assessed an antibody-drug conjugate from the partners' pipeline and recorded a higher than expected rate of interstitial lung disease, with some cases described as severe and fatal. The new data provide investors with fresh information on both...
Yahoo · Oct 28, 2026
Moderna stock is surging even after an analyst cited its 636% yearly gain as reason enough to step back, and the real question is whether Wall Street is pricing in a cancer breakthrough that has yet to prove itself outside one tumor type.
Yahoo · Oct 28, 2026
Pfizer heads into Q3 earnings with strong drug sales and an attractive valuation, but declining COVID revenues and looming patent expirations pose challenges.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BNTX.
